Korro Bio merges with off-pitch Frequency, hits Wall Street with $117M

Korro Bio merges with off-pitch Frequency, hits Wall Street with $117M

Source: 
Fierce Biotech
snippet: 

Reverse mergers are all the rage as cash-depleted public biotechs search for viable next chapters, with Korro Bio and Frequency Therapeutics the latest to fuse.